Monday, March 1, 2021

Cipla gets USFDA nod for migraine drug

Cipla gets USFDA nod for migraine drug The newly approved product is a generic therapeutic equivalent version of GlaxoSmithKline#39;s Imitrex Nasal Spray.

from Moneycontrol Business News https://ift.tt/2OhK3rC

No comments:

Post a Comment

Bulls return to D-Street as falling oil prices ease geopolitical jitters

Indian stock markets experienced a significant rally on Wednesday. Both the Nifty 50 and S&P BSE Sensex saw gains exceeding 1 percent. T...